🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The study is designed as a Phase III, double-blind, multi-center, randomize...
Status
Unknown
Location
Center for Vaccine Development
Start Date
2022-09-16
Trial ID
NCT05447377
Treatments Being Tested
dMMR/MSI-H is a key molecular subtype of gastric cancer, found in 8-22% of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-31
Trial ID
NCT07259473
Treatments Being Tested
This clinical trial will be conducted as a single-center, open-label, Phase...
Status
Terminated
Location
University of Iowa Hospitals and Clinics
Start Date
2020-10-05
Trial ID
NCT04108481
Treatments Being Tested
The purpose of the study is to compare the immunological response of homeop...
Status
Unknown
Location
McMaster University
Start Date
2016-09
Trial ID
NCT02825368
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2020-02-20
Trial ID
NCT04104893
Treatments Being Tested
Solid tumours are abnormal lumps of tissue that can occur in different part...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-10-20
Trial ID
NCT07213609
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and tolerability ...
Status
Recruiting
Location
Liverpool Cancer Therapy Centre
Start Date
2025-11
Trial ID
NCT07244705
Treatments Being Tested
The purpose of this study is to assess immune response and safety of variou...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-03
Trial ID
NCT05084508
Treatments Being Tested